Addressing the Issues that Trikafta Benefits Will Bring
It’s time to move forward. The recent approval by the U.S. Food and Drug Administration of the triple-combination treatment Trikafta (elexacaftor, tezacaftor, and ivacaftor) has sparked hope in the cystic fibrosis community. While it’s not a cure, the therapy has shown to have positive…